Ongoing Research Projects | Foundation for a Smoke-Free World

ongoing research projects

The Foundation aims to develop the next generation of worldwide leaders and institutions that will accelerate progress toward achieving a smoke-free world by supporting:

  • Centers of Excellence for science-based research and innovation in the fields of smoking cessation and tobacco harm reduction
  • Efforts that address ethical, legal, and social issues that hamper progress aimed at helping smokers quit or switch to reduced-risk alternatives

research projects by centers of excellence

  • Center of Excellence for the Acceleration of Harm Reduction (CoEHAR): The Promotion of Quality Research for Tobacco Harm-Reduction Science
  • Rose Research Center, LLCTranslational Research Center to Promote a Smoke-Free World
  • The Centre of Research Excellence: Indigenous Sovereignty & Smoking (COREISS): Proposal to Build a Global Centre for Smoking Cessation and Harm Reduction in Indigenous Peoples

other research projects

  • Lumos Diagnostics: The Development of a Rapid Point-of-Care (POC) Assay Panel That Will Be Able to Differentiate Multi-Use of Nicotine Products
  • Behavioral Diagnostics LLCAn Integrated Epigenetic ELISA Saliva Kit for Detecting & Quantifying the Use of Tobacco and Nicotine Products
  • Analytisch-biologisches Forschungslabor (ABF GmbH): Identification of Biomarkers of Exposure Specific to Different Nicotine Product User Groups
  • Cambridge Design Partnership Ltd: Looking to the Future: Emerging Innovations to End Smoking – Phase 2: Addressing Impediments to the Adoption of Reduced-Risk Products in Low- and Middle-Income Countries
  • Avesthagen: Assessing the Cancer Risk in Smoking Subjects by Next-Generation Sequencing (NGS) Profiling of Circulating Free DNA and RNA; and Creating a Genome Database of Nonsmoking Populations (The Avestagenome Project) to Identify New Genes That Predispose Individuals to Cancer
  • Etheim Biotics LLC: Smoking Dysbiosis and Restorative Methods: Probiotic Approaches to Restore the Human Microbiome in Those Who Have Recently Quit Cigarette Smoking
  • Botec: Multi-disciplinary investigation into the drivers for smoking cessation in five countries with alternative nicotine delivery systems (ANDS) markets
  • Ernst & Young and Executive Insight: Systems-level analysis and lessons from countries with significant reductions in smoking prevalence
  • Metaform Ventures: Indian smokeless tobacco product characterization
  • Embera Neuro Therapeutics: Clinical trial material for tobacco use disorder
WordPress Appliance - Powered by TurnKey Linux